Endocrine Abstracts

The major source of neurokinin B (NKB), a peptide of the tachykinin family, is the placenta. Little is known of the regulation of NKB or its preferred hypertensive-inducing receptor, NK3, during pregnancy, nor, the mechanisms leading to elevated NKB associated with pre-eclampsia (PE) during the third trimester. Using the pregnant rat we have looked at the changes in NKB and NK3 expression using real time PCR between day 16 and 21 of gestation in the placenta, brain and differe...

Substance P (SP), neurokinin A and neurokinin B (NKB) are vasoactive tachykinins, believed to exert their effects by release from nerve endings to activate three neurokinin receptors. We have found the major source of NKB (TAC3) expression to be the placenta which results in elevated maternal blood levels in pre-eclampsia. Placental NKB appears to increase blood flow in the placenta and uterus but causes pressor effects in the peripheral circulation. Whilst the placenta, is de...